
Dual-action GLP‑1/GIP for faster results
- From
- $149/mo
- Taken
- Once-weekly injection
- Type
- Dual GLP‑1/GIP agonist
Sources
- ZEPBOUND (tirzepatide) injection, prescribing information and single-dose vial Instructions for Use. DailyMed, U.S. National Library of Medicine.
- Tirzepatide Injection. MedlinePlus, U.S. National Library of Medicine.
- Subcutaneous (SQ) injections. MedlinePlus Medical Encyclopedia.
- Drawing medicine out of a vial. MedlinePlus Medical Encyclopedia.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration.
- Best Way to Get Rid of Used Needles and Other Sharps. U.S. Food and Drug Administration.
Keep reading
All 150 articles →- Tirzepatide
Tirzepatide vs Retatrutide: What You Can Start Today vs What's Still in Trials
One is an approved medication you can start this month. The other is a promising investigational drug still working through phase 3. Here is how they compare, and what the retatrutide headlines leave out.
By Arbor Health Team
- Tirzepatide
Zepbound vs Wegovy: Tirzepatide vs Semaglutide by Results, Price & Access
Zepbound is tirzepatide. Wegovy is semaglutide. One head-to-head trial, two very different price paths, and a new pill complicate the choice. Here is the honest comparison.
By Arbor Health Team
- Tirzepatide
Foundayo vs Zepbound: A Daily Pill or a Weekly Tirzepatide Shot?
Foundayo is a once-daily GLP-1 pill you can take with or without food. Zepbound is the weekly tirzepatide injection with the larger trial results. Here is how they compare, and where the Wegovy pill fits.
By Arbor Health Team






